Terms: = Leukemia AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H
418 results:
1. Effective delivery of anti-pd-l1 siRNA with human heavy chain ferritin (HFn) in acute myeloid leukemia cell lines.
Rajabinejad M; Valadan R; Tehrani M; Najafi A; Negarandeh R; Saeedi M; Asgarian-Omran H
Med Oncol; 2024 May; 41(6):149. PubMed ID: 38739199
[TBL] [Abstract] [Full Text] [Related]
2. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.
Burris HA; Okusaka T; Vogel A; Lee MA; Takahashi H; Breder V; Blanc JF; Li J; Bachini M; Żotkiewicz M; Abraham J; Patel N; Wang J; Ali M; Rokutanda N; Cohen G; Oh DY
Lancet Oncol; 2024 May; 25(5):626-635. PubMed ID: 38697156
[TBL] [Abstract] [Full Text] [Related]
3. A novel TCGA-validated programmed cell-death-related signature of ovarian cancer.
Cai X; Lin J; Liu L; Zheng J; Liu Q; Ji L; Sun Y
BMC Cancer; 2024 Apr; 24(1):515. PubMed ID: 38654239
[TBL] [Abstract] [Full Text] [Related]
4. Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells.
Camoglio C; Balla J; Fadda P; Dedoni S
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611871
[TBL] [Abstract] [Full Text] [Related]
5. Associations of PD-1 and pd-l1 gene polymorphisms with cancer risk: a meta-analysis based on 50 studies.
Yang M; Liu Y; Zheng S; Geng P; He T; Lu L; Feng Y; Jiang Q
Aging (Albany NY); 2024 Mar; 16(7):6068-6097. PubMed ID: 38546391
[TBL] [Abstract] [Full Text] [Related]
6. Different Influence Pattern of Conventional and Alternative Sources of Smoking on Adhesion Molecules and Cytokine Secretion in THP-1 Monocytes.
Mohr T; Probst E; Idel C; Plötze-Martin K; Fleckner J; Rades D; Drömann D; Bohnet S; Bruchhage KL; Franzen KF; Pries R
Anticancer Res; 2024 Apr; 44(4):1455-1464. PubMed ID: 38537980
[TBL] [Abstract] [Full Text] [Related]
7. HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer.
Saigí M; Mate JL; Carcereny E; Martínez-Cardús A; Esteve A; Andreo F; Centeno C; Cucurull M; Mesia R; Pros E; Sanchez-Cespedes M
Lung Cancer; 2024 Mar; 189():107502. PubMed ID: 38359742
[TBL] [Abstract] [Full Text] [Related]
8.
Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212126
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological Study of PD-1/pd-l1 Expression in Chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma (CLL/SLL) with Emphasis on Large B-Cell Richter Transformation.
Masoud R; Eladl AE; El-Ashwah S; Abbas A; Kandil W
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4243-4252. PubMed ID: 38156860
[TBL] [Abstract] [Full Text] [Related]
10. TIGIT is Frequently Expressed in the Tumor Microenvironment of Select Lymphomas: Implications for Targeted Therapy.
Libert D; Zhao S; Younes S; Mosquera AP; Bharadwaj S; Ferreira C; Natkunam Y
Am J Surg Pathol; 2024 Mar; 48(3):337-352. PubMed ID: 38148663
[TBL] [Abstract] [Full Text] [Related]
11. Whole-genome CRISPR screening identifies molecular mechanisms of pd-l1 expression in adult T-cell leukemia/lymphoma.
Chiba M; Shimono J; Suto K; Ishio T; Endo T; Goto H; Hasegawa H; Maeda M; Teshima T; Yang Y; Nakagawa M
Blood; 2024 Apr; 143(14):1379-1390. PubMed ID: 38142436
[TBL] [Abstract] [Full Text] [Related]
12. PD-1/pd-l1 Interaction Regulates BCL2, KI67, BAX, and CASP3, Altering Proliferation, Survival, and Apoptosis in Acute Myeloid leukemia.
Soltani M; Vosoughi M; Ganjalikhani-Hakemi M; Shapoorian H; Beshkar P; Eskandari N; Ghezelbash B
Iran J Allergy Asthma Immunol; 2023 Oct; 22(5):495-503. PubMed ID: 38085150
[TBL] [Abstract] [Full Text] [Related]
13. Development of PD-1 blockade peptide-cell conjugates to enhance cellular therapies for T-cell acute lymphoblastic leukemia.
Wang Q; Huang H; Liang P; Wang L; Zheng J; Zhang Y; Wang H
Med Oncol; 2023 Dec; 41(1):14. PubMed ID: 38078948
[TBL] [Abstract] [Full Text] [Related]
14. Richter transformation-is there light at the end of this tunnel?
Eyre TA
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):427-432. PubMed ID: 38066897
[TBL] [Abstract] [Full Text] [Related]
15. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.
Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J
Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258
[TBL] [Abstract] [Full Text] [Related]
16. Combination therapy of acute myeloid leukemia by dual PI3K/mTOR inhibitor BEZ235 and TLR-7/8 agonist R848 in murine model.
Taghiloo S; Ajami A; Alizadeh-Navaei R; Asgarian-Omran H
Int Immunopharmacol; 2023 Dec; 125(Pt B):111211. PubMed ID: 37956488
[TBL] [Abstract] [Full Text] [Related]
17. Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis.
Wang QM; Lian GY; Sheng SM; Xu J; Ye LL; Min C; Guo SF
Mol Cancer Res; 2024 Feb; 22(2):125-136. PubMed ID: 37889101
[TBL] [Abstract] [Full Text] [Related]
18. Combined or Sequential Treatment with Immune Checkpoint Inhibitors and Car-T Cell Therapies for the Management of Haematological Malignancies: A Systematic Review.
Pérez-Moreno MA; Ciudad-Gutiérrez P; Jaramillo-Ruiz D; Reguera-Ortega JL; Abdel-Kader Martín L; Flores-Moreno S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834228
[TBL] [Abstract] [Full Text] [Related]
19. Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease.
Bailey C; Wei Y; Yan J; Huang D; Zhang P; Qi C; Lazarski C; Su J; Tang F; Wong CS; Zheng P; Liu Y; Liu Y; Wang Y
Cell Rep Med; 2023 Nov; 4(11):101236. PubMed ID: 37827154
[TBL] [Abstract] [Full Text] [Related]
20. Progress of research on PD-1/pd-l1 in leukemia.
Cao H; Wu T; Zhou X; Xie S; Sun H; Sun Y; Li Y
Front Immunol; 2023; 14():1265299. PubMed ID: 37822924
[TBL] [Abstract] [Full Text] [Related]
[Next]